Cost-effectiveness simulation analysis of tenofovir disoproxil fumarate (tenofovir), lamivudine, adefovir dipivoxil (adefovir) and entecavir of HBeAg negative (-) patients with chronic hepatitis-B (CHB) in Spain

被引：2
作者：
Deniz, B. [1 ]
Buti, M. [2 ]
Brosa, M. [3 ]
Casado, M. A. [5 ]
Rueda, M. [4 ]
Everhard, F. [4 ]
Esteban, R.
机构：
[1] United BioSource Corp, Concord, MA USA
[2] Hosp Vall D Hebron, Dept Hepatol, Barcelona, Spain
[3] Oblikue Consulting, Barcelona, Spain
[4] Gilead Sci Inc, Foster City, CA USA
[5] Pharmacoecon & Outcomes Res, Madrid, Spain
来源：
JOURNAL OF HEPATOLOGY | 2008年 / 48卷
关键词：
D O I：
10.1016/S0168-8278(08)60560-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
558
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
[41]   TREATMENT RESPONSE OF COMBINED LAMIVUDINE PLUS ADEFOVIR DIPIVOXIL OR ENTECAVIR MONOTHERAPY IN ADEFOVIR-RESISTANT CHRONIC HEPATITIS B PATIENTS [J].
Chen, Chien-Hung ;
Wang, Jing-Houng ;
Lu, Sheng-Nan ;
Hu, Tsung-Hui ;
Hung, Chao-Hung ;
Lee, Chuan-Mo .
HEPATOLOGY, 2010, 52 (04) :551A-551A
[42]   Therapeutic effectiveness analysis of tenofovir alafenamide and tenofovir disoproxil fumarate on the treatment for chronic hepatitis B [J].
Liu, Rui ;
Qiao, Jin ;
Zhang, Lin ;
Dou, Zhihua .
MEDICINE, 2024, 103 (20) :E37953
[43]   TENOFOVIR DISOPROXIL FUMARATE FOR PATIENTS WITH CHRONIC HEPATITIS B WHO HAVE PREVIOUSLY FAILED LAMIVUDINE AND ADEFOVIR: EFFECTS OF BASELINE SEQUENCE MUTATIONS ON VIROLOGICAL RESPONSE [J].
Patterson, Scott ;
George, Jacob ;
Strasser, Simone I. ;
Lee, Alice U. ;
Sievert, William ;
Nicoll, Amanda J. ;
Desmond, Paul V. ;
Roberts, Stuart K. ;
Locarnini, Stephen ;
Bowden, Scott ;
Angus, Peter W. .
HEPATOLOGY, 2009, 50 (04) :534A-535A
[44]   Tenofovir alafenamide is superior to tenofovir disoproxil fumarate and entecavir in cost-effectiveness of treatment of chronic hepatitis B in china with new volume-based procurement policy [J].
Lin, Yi ;
Lin, Xueyan ;
Xia, Ruiqi ;
Chen, Juan ;
Lin, Zhihui ;
Lu, Shiyun .
PLOS ONE, 2025, 20 (07)
[45]   Adefovir dipivoxil (ADV) demonstrates sustained efficacy in HBeAg- chronic hepatitis B (CHB) patients [J].
Hadziyannis, S ;
Tassopoulos, N ;
Chang, TT ;
Heathcote, J ;
Kitis, G ;
Rizzetto, M ;
Marcellin, P ;
Lim, SG ;
Arterburn, S ;
Ma, J ;
Xiong, S ;
Brosgart, CL ;
Currie, G .
JOURNAL OF HEPATOLOGY, 2005, 42 :178-178
[46]   Treatment of patients with lamivudine-resistant and adefovir dipivoxil-resistant chronic hepatitis B virus infection: is tenofovir the answer? [J].
Trojan, J. ;
Stuermer, M. ;
Teuber, G. ;
Berger, A. ;
Faust, D. .
GUT, 2007, 56 (03) :436-437
[47]   Adefovir dipivoxil (ADV) demonstrates sustained efficacy in HBeAg- chronic hepatitis B (CHB) patients [J].
Hadziyannis, S ;
Tassopoulos, N ;
Chang, TT ;
Heathcote, J ;
Kitis, G ;
Rizzetto, M ;
Marcellin, P ;
Lim, SG ;
Arterburn, S ;
Ma, J ;
Xiong, S ;
Brosgart, CL ;
Currie, G .
GASTROENTEROLOGY, 2005, 128 (04) :A693-A693
[48]   Adefovir dipivoxil (ADV) for the treatment of patients with chronic hepatitis B (CHB) failing lamivudine (LAM) therapy [J].
Zoulim, F ;
Trepo, C ;
Poynard, T ;
Pol, S ;
Zarski, JP ;
Marcellin, P ;
Beaugrand, M ;
Stitruk, V ;
Trylesinski, A ;
Kleber, K ;
Van Doren, S ;
Brosgart, C .
JOURNAL OF HEPATOLOGY, 2003, 38 :184-184
[49]   Entecavir plus tenofovir vs. lamivudine/telbivudine plus adefovir in chronic hepatitis B patients with prior suboptimal response [J].
Woo, Hyun Young ;
Park, Jun Yong ;
Bae, Si Hyun ;
Kim, Chang Wook ;
Jang, Jae Young ;
Tak, Won Young ;
Kim, Dong Joon ;
Kim, In Hee ;
Heo, Jeong ;
Ahn, Sang Hoon .
CLINICAL AND MOLECULAR HEPATOLOGY, 2020, 26 (03) :352-363
[50]   Tenofovir-based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir [J].
Kim, Byung Gyu ;
Jung, Seok Won ;
Kim, Eun Hye ;
Kim, Jae Hee ;
Park, Ju Hwan ;
Sung, Shi Jung ;
Park, Bo Ryung ;
Kim, Min-Ho ;
Kim, Chang Jae ;
Lee, Byung Uk ;
Park, Jae Ho ;
Jeong, In Du ;
Bang, Sung-Jo ;
Shin, Jung Woo ;
Park, Neung Hwa .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (10) :1514-1521
12345